SEC Form 4 · accession 0001179110-17-005249
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William McKee
Director
Period of report
Mar 28, 2017
Accepted (ET)
Mar 30, 2017 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $14.23 | Mar 28, 2017 | A | 29,268 | A | — | Mar 28, 2027 | Common Stock | 29,268 | 29,268 | D |
Explanation of responses
- F1These stock options are exercisable in 36 equal monthly installments.